The Marion Larat case, a young Bordeaux woman severely disabled after a stroke in 2006 that she attributes to the 3rd generation pill, experienced a double rebound with the decision to investigate the case in criminal proceedings, and the granting of a consequent civil compensation.
Read also: Contraceptive pills: what are the contraindications?
In a case that has become emblematic for women claiming to be victims of side effects of hormonal contraceptives, Marion Larat was at the end of 2012 the first French woman to file a complaint, for "
involuntary harm to the integrity of the person
", after a stroke suffered at 18, linked according to her to the Méliane pill, produced by the German group Bayer.
The massive stroke, which disabled her by 65%, was first attributed to a heart defect.
But in 2011, the causal link between taking this pill and the accident was recognized by the regional commission for conciliation and compensation for medical accidents.
At the time, the case had pushed the health authorities to anticipate the delisting of “
”, and paved the way for some 130 other complaints, centralized at the public health center of the Paris prosecutor's office.
But in 2017, the prosecution classified the investigation concerning 29 brands of 3rd and 4th generation contraceptive pills.
Marion's lawyer then filed a complaint with civil proceedings, leading to the appointment of an investigating judge, but a dismissal order was issued in October 2018. Me Coubris had appealed.
In a judgment in July, of which AFP was aware, the investigating chamber of the Paris Court of Appeal considered that "
it was wrongly considered that the causal link between the taking of (the pill Méliane) and the stroke had not been established with certainty
Read also: Contraception: no, the pill does not shrink women's brains
Me Jean-Christophe Coubris, lawyer for Marion Larat, said Monday, October 26 his "
" to see appointed an investigating judge, who should hear Marion Larat "
by the end of the year
But he also expressed his "
disgust that eight years must have passed
" before having the certainty of an instruction with a guarantee of "
The subject is still there
At the same time, at the civil level, Marion Larat, whose justice had recognized the quality of victim of "
a medical accident not at fault
", was awarded by a judgment in September of the judicial court of Bordeaux, of which AFP has In this copy, compensation for damages of 4.5 million euros paid by the National Office for Compensation for Medical Accidents (Oniam).
In February 2018, Oniam had already had to pay a provision of 550,000 euros.
Marion, who had had to interrupt promising studies after her stroke, is now a 33-year-old young mother, who has just given birth to a second child.
In front of the press, she called on Monday women suffering from the after-effects of pills "
not to feel guilty or at fault but indeed victims of the pill, and to fight, to file a complaint
She says she remains prone to epileptic seizures, aphasia (language disorder) which also affects her writing, suffers from hemiplegia of the right hand, from "
, and affirms "that
she does not can never work
She recalled in tears the case of Maylis, a young woman who died in 2012 of a pulmonary embolism linked according to her to the 3rd generation pill, "
three weeks before my affair begins, before I speak
Read also: The decline of 3rd and 4th generation pills has a visible positive effect
In a parallel with the launch of the alert by Irène Frachon in the case (of the antidiabetic) Mediator, Me Coubris considered that "
if we had not had in 2012 the courage of Marion, not the first victim of pills , but the first to cry out (...), we would still have as many 3rd and 4th generation pills sold, prescribed in first intention, as many accidents
the subject is still there
insisted the lawyer, following "
" pills legacy files.
And aims, beyond a condemnation of Bayer in this case, the laboratories which "
continue to market these pills
" and show, according to him, a "
condemnable lightness in view of the information that see you today
Asked by AFP, Bayer had not reacted at the end of the day.